Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 11.25
0.00 (0.00%)
Oct 10, 2025, 4:38 PM GMT+1
Creo Medical Group Revenue
Creo Medical Group had revenue of 2.20M GBP in the half year ending June 30, 2025, a decrease of -85.99%. This brings the company's revenue in the last twelve months to 4.60M, down -250.82% year-over-year. In the year 2024, Creo Medical Group had annual revenue of 4.00M.
Revenue (ttm)
4.60M
Revenue Growth
-250.82%
P/S Ratio
9.84
Revenue / Employee
35.66K
Employees
129
Market Cap
45.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.00M | - | - |
| Dec 31, 2023 | 4.00M | -23.20M | -85.29% |
| Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
| Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
| Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Creo Medical Group News
- 12 days ago - Creo Medical Group PLC (CMEOF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Creo Medical Group PLC 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha